Dubai, United Arab Emirates.-Sunday, May 20th 2018 [ AETOS Wire ] The latest air compressor in Atlas Copco’s smart AIR solutions portfolio, the GA 90+-160 (VSD+) oil-injected screw compressor range is designed for reduced energy consumption and ease of installation and service. It features state-of-the-art compression elements with Smart Injection technology coupled with highly efficient oil-cooled IE4 and IE5 motors that require no service interventions. The new Elektronikon® Touch controller with integrated smart algorithms further reduce energy consumption. It is available in water- and air-cooled versions, with fixed or variable speed drive and with an optional integrated dryer. “The latest generation of GA compressors are particularly well suited to the mining industry, metal processing and power plants where its IP66 drive train offers complete protection from environmental dust and moisture ensuring reliable operation even in ​the harshest environmental conditions. This reliabi ... Read more »

Dubai, United Arab Emirates-Tuesday, May 15th 2018 [ AETOS Wire ] If 36-year-old Sylvester E. had to stay in Nigeria, he may not have lived to see his middle-age years. Thanks to Dr. Allam Alkowatli, Chief of Cardiovascular Medicine and Consultant Interventional Cardiologist at Emirates Hospital, Sylvester was able to travel to Dubai to receive the life-saving surgery that he needed. What Sylvester needed was Cardio Balloon Valvuloplasty surgery to open up a stiff tight valve in his heart that was causing him chest pain, trouble breathing and suffocation, palpitations as well as a host of other health-related problems. When Sylvester began to notice problems breathing, while doing minor everyday activities, he made an appointment to see his physician in Nigeria, who told him he had a major problem in his heart, maybe a hole, to find out later it was more serious. However, realizing he was dealing with a life-threatening condition, Sylvester immediately began to research online for t ... Read more »

– Data Being Presented Underscore Commitment to Improving Patient Outcomes and Care – – Six Takeda Oncology-Sponsored Abstracts Accepted for Presentation at ASCO 2018 and Eight Abstracts Accepted for Presentation at EHA 2018 – CAMBRIDGE, Mass. & OSAKA, Japan-Sunday, May 20th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming medical meetings: the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5 in Chicago and the 23rd Congress of the European Hematology Association (EHA), June 14-17 in Stockholm. This year’s presentations will underscore Takeda’s unwavering pursuit to advance hematologic cancer therapy and continue building upon research in difficult-to-treat solid tumors. “At ASCO and EHA we will present data, real-world findings and trial updates on our pipeline assets as well as our marketed ... Read more »

BRISBANE, Australia-Tuesday, May 15th 2018 [ AETOS Wire ] Key points: Anatara has signed an exclusive agreement with Zoetis Inc., the leading global animal health company, to license Detach® - Anatara’s non-antibiotic approach to aid in the control of diarrhoeal disease in livestock and horses Zoetis to manage worldwide development, manufacturing, distribution and marketing of Detach® for livestock animals and horses Agreement represents the achievement of a major milestone for Anatara and its shareholders (BUSINESS WIRE) -- Anatara Lifesciences (ASX:ANR) is delighted to announce an exclusive licensing agreement with Zoetis Inc., the leading global animal health company, for the worldwide development, manufacture, distribution and marketing of Detach® as a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour) in livestock and in horses. Under the terms of the license agreement, Anatara has granted Zoetis exclusive rights to develop, manufacture, di ... Read more »